July 14, 2022
According to the research report titled ‘Global Intracranial Pressure Monitoring Devices Market Size study, byBy Technique (Invasive , Non-invasive ), by Application ( Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, Subarachnoid Hemorrhage, CSF Management, Migraine, Stroke Hydrocephalus, EEG, Others) and Regional Forecasts 2022-2028’, available with MarketStudyReport, global intracranial pressure monitoring devices market is anticipated to witness considerable growth by the year 2028.
The rising prevalence of neurological disorders, the growing geriatric population, and technological advancements are some of the prime factors driving the expansion of global intracranial pressure monitoring devices market.
Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5110038/
Apart from this, the rising incidence of trauma events, growing patient awareness, positive outlook toward non-ICU hospitalization recovery room, post-discharge communication, rapid mobilization, growing adoption of minimally invasive operations, TIVA anesthesia, and early post imaging capabilities will contribute toward the overall market growth as well.
For those unaware, the development and application of non-invasive intracranial pressure monitoring techniques are known to decrease the possibility of negative side effects and aid in cutting the monitoring costs and improve patient satisfaction.
Based on technique, the market is divided into non-invasive and invasive.
Moving on to the application spectrum, global intracranial pressure monitoring devices industry is fragmented into EEG, hydrocephalus, stroke, migraine, CSF management, subarachnoid hemorrhage, meningitis, intracerebral hemorrhage, traumatic brain injury, and others.
Geographically, North America market is expected to grow substantially over the forecast period, owing to technological breakthroughs, rising demand for minimally invasive surgeries, the growing prevalence of trauma cases & neurological illnesses, and the surging adoption of noninvasive ICP monitoring treatments.
Meanwhile, intracranial pressure monitoring devices industry size in Asia Pacific is projected to grow considerably during the review period, ascribed to the growing prevalence of sports injuries and trauma.
Nisonic, IRRAS AB, NovaSignal Corp., Gaeltec Devices Ltd., Natus Medical Incorporated, Spiegelberg GmbH & Co. KG, Sophysa, Raumedic AG, Integra LifeSciences, and Medtronic plc are the leading players operating in global intracranial pressure monitoring devices industry.